The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,534,247 in first-year total cost, median $1,337,032.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-D (06)]3
- Special Emphasis Panel[ZDA1 JXR-D (10)]2
- Special Emphasis Panel[ZDA1 JXR-D (09)]1
Most frequent institutions
- ANTIDOTE THERAPEUTICS, INC.1
- CERECOR. INC.1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- HENNEPIN HEALTHCARE RESEARCH INSTITUTE1
- HEPTARES THERAPEUTICS, LTD1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Non-Metabolized Pregnenolone Derivatives:New Treatment for Cannabis Use Disorder1R01DA038875-01A1 | HANEY, MARGARET | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $1,649,677 | ZDA1 |
| 2016 | Phase 1 safety-interaction study of pomaglumetad methionil for methamphetamine use disorder1R01DA043238-01 | HEINZERLING, KEITH GREGORY | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,024,387 | ZDA1 |
| 2016 | CERC-501 Kappa Antagonist for Nicotine Dependence1R01DA040976-01 | COMER, SANDRA DMARCUS, RONALD NWALSH, SHARON L. | CERECOR. INC., MD | $1,020,517 | ZDA1 |
| 2016 | Enhancing efficacy of vaccines for substance abuse through polymer-assisted delivery of immunomodulators1R01DA041730-01 | PRAVETONI, MARCO | HENNEPIN HEALTHCARE RESEARCH INSTITUTE, MN | $439,201 | ZDA1 |
| 2015 | Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence1R01DA039553-01 | MARSHALL, FIONA | HEPTARES THERAPEUTICS, LTD | $1,847,427 | ZDA1 |
| 2014 | Lead Optimization and Preclinical Development of Human Nicotine-Specific mAbs1R01DA038877-01 | KALNIK, MATTHEW W | ANTIDOTE THERAPEUTICS, INC., MD | $2,553,038 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.